Medication Persistence and Its Impact on Type 2 Diabetes : v

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.

Related Keywords

United Kingdom , United States , American , Los Angeles , Jeeh Choe , Acta Diabetol , Paprockiy Semaglutide , Value Health , American Diabetes Association Professional Practice Committee , International Classification Of Diseases , American Hospital Formulary Service , D International Classification Of Diseases , Health Care , Health Economics , Popul Health Manag , Health Aff Millwood , University Of Southern California Institutional Review Board , American Diabetes Association , University Of Southern California , Department Of Clinical Pharmacy , Alfrede Mann School Of Pharmacy , Institute Inc , National Diabetes Statistics , Optum Clinformatics Data Mart , Medicare Advantage , Diabetes Association , Clinformatics Data Mart , Southern California Institutional Review , International Classification , Ninth Revision , Clinical Modification , Tenth Revision , Initial Treatment , Appendix Table , Clinical Drug Information , Drug Information , Charlson Comorbidity Index , Appendix Tables , United Kingdom Prospective Diabetes Study , Diabetes Complications Severity Index , Clinical Pharmacy , Pharmaceutical Sciences , Southern California , Diabetes Statistics Report , Its Burden , Diabetes Association Professional Practice , Medical Care , Med Res , Diabetes Obes , Metab Syndr , Aging Study , Medication , Persistence , Diabetes , T2d ,